Area of research
Parasitology · Ecology
Research interest
Research interests include Parasites and Host Interactions, Parasite Biology and Host Interactions, Parasitic Diseases Research and Treatment, and Global Maternal and Child Health.
School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks.
The Current and Future Burden of Long COVID in the United States.
It won't end with COVID: Countering the next phase of American antivaccine activism 2025-29.
Measles, Mumps, Rubella Immunization and the Resurgence of Measles in America.
Vaccines in a time of global boiling and megacities
School-Level Gaps in MMR Coverage as the Fuel for Measles Outbreaks
Navigating your US bioscience career into the 2030s.
Virology—the path forward
Vaccines and therapeutics for immunocompromised patients with COVID-19
Vaccine access, equity and justice: COVID-19 vaccines and vaccination.
Factors, enablers and challenges for COVID-19 vaccine development.
SARS-CoV-2 variants offer a second chance to fix vaccine inequities.
COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats.
Progress in vaccine development for infectious diseases—a Keystone Symposia report
Global regulatory reforms to promote equitable vaccine access in the next pandemic.
Poverty associated with the environmental contamination of gastrointestinal parasites in the Southern United States
Anti-science conspiracies pose new threats to US biomedicine in 2023.
The Lancet Commission on lessons for the future from the COVID-19 pandemic
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine.
The great Texas COVID tragedy.
Vietnam: Neglected tropical diseases in an emerging and accelerating economy.
Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon.
Identification of vaccine targets in pathogens and design of a vaccine using computational approaches
Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants
Update on SARS-CoV-2 seroprevalence: regional and worldwide
A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice.